Patents by Inventor Tina Meinertz Andersen

Tina Meinertz Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for IVF
    Patent number: 6988613
    Abstract: A solid, stable composition containing a meiosis activating substance can be prepared by adding a protein or a phosphoglycid in the presence of an atmosphere having a low content of oxygen, for example in vacuo.
    Type: Grant
    Filed: February 5, 2002
    Date of Patent: January 24, 2006
    Assignee: Novo Nordisk A/S
    Inventors: Tina Meinertz Andersen, Lars Klingberg Muller
  • Composition containing a meiosis activating substance
    Patent number: 6844313
    Abstract: A solid composition containing a meiosis activating substance can be prepared by adding a protein or a phosperglycid.
    Type: Grant
    Filed: September 14, 2000
    Date of Patent: January 18, 2005
    Assignee: Novo Nordisk A/S
    Inventor: Tina Meinertz Andersen
  • Composition for IVF
    Publication number: 20020166789
    Abstract: A solid, stable composition containing a meiosis activating substance can be prepared by adding a protein or a phosphoglycid in the presence of an atmosphere having a low content of oxygen, for example in vacuo.
    Type: Application
    Filed: February 5, 2002
    Publication date: November 14, 2002
    Inventors: Tina Meinertz Andersen, Lars Klingberg Muller
  • Modified release formulations containing (R)-1-(10,11-dihydro-5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1propyl)-3-piperidinecarboxylic acid
    Patent number: 6207682
    Abstract: Modified release formulations with zero-order drug release containing (R)-1-(3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-propyl)-3-piperidinecarboxylic acid, or a pharmaceutically acceptable salt thereof, dispersed in a polymeric matrix having at least one release rate controlling polymer are useful in treating disorders related to both neurogenic inflammation and non-insulin-dependent diabetes mellitus (NIDDM).
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: March 27, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Tina Meinertz Andersen, Thyge Borup Hjorth, Kim Westi Jorgensen
  • Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
    Patent number: 5866590
    Abstract: The present invention provides a new stable pharmaceutical composition containing tiagabine hydrochloride as active ingredient.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: February 2, 1999
    Assignee: Novo Nordisk A/S
    Inventors: J.o slashed.rgen Ryhl Svensson, Lars Nygaard, Tina Meinertz Andersen, Helle Weibel, Thyge Borup Hjorth